SCHEMBL10045773

SCHEMBL10045773

CC(C)OOOOO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10071984 0.97
SCHEMBL27353516 0.97
SCHEMBL14087093 0.97
SCHEMBL2631621 0.97
SCHEMBL3509878 0.97
SCHEMBL10017792 0.97
SCHEMBL12126993 0.90
SCHEMBL10638007 0.78 ALDH1A1 (0.32)
SCHEMBL2086197 0.78 ALDH1A1 (0.32)
SCHEMBL14117024 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8309662-B2 Polybenzimidazole-polyetherketoneketone blends and miscible blends PBI PERFORMANCE PRODUCTS, INC. (US) 2012-11-13 US disclosed
EP-2512093-A1 Improvements to an agile network protocol for secure communications with assured system availability VirnetX Inc. (US) 2012-10-17 EP disclosed
EP-2421220-A1 Improvements to an agile network protocol for secure communications with assured system availability VirnetX Inc. (US) 2012-02-22 EP disclosed
EP-2381650-A1 Secure domain name service VirnetX Inc. (US) 2011-10-26 EP disclosed
EP-2312808-A1 Improvements to an agile network protocol for secure communications with assured system availability VirnetX Inc. (US) 2011-04-20 EP disclosed
US-20100305277-A1 POLYBENZIMIDAZOLE-POLYETHERKETONEKETONE BLENDS AND MISCIBLE BLENDS DAWKINS BOBBY G 2010-12-02 US disclosed
US-7829679-B2 Mucin-type glycoprotein and use thereof RIKEN (JP) 2010-11-09 US disclosed
US-20100193785-A1 SEMICONDUCTOR DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-08-05 US disclosed
US-20100151514-A1 NOVEL MUCIN-TYPE GLYCOPROTEIN AND USE THEREOF RIKEN (JP) 2010-06-17 US disclosed
US-20090263455-A1 Dexamethasone Formulations in a Bioegradable Material WARSAW ORTHOPEDIC, INC. (US) 2009-10-22 US disclosed
US-20090148858-A1 METHODS FOR CHARACTERIZING BIOLOGICAL MOLECULE MODULATORS EKSIGENT TECHNOLOGIES, LLC (US) 2009-06-11 US disclosed